In agreement with previous studies by Denlinger et al. using NSCLC cell lines (A549 and H157) [18], we observed that low dose gemcitabine enhanced NF-κB activity in A549 and H157 cells. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.